INBIOGEN CO., Ltd. (101140) Financial Statements

― Followers

INBIOGEN CO., Ltd. Financial Overview

INBIOGEN CO., Ltd.'s market cap is currently ₩50.62B. The company's EPS TTM is ₩-4161.7; its P/E ratio is -1.20; INBIOGEN CO., Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	₩ 6.30B	₩ 7.04B	₩ 6.24B	₩ 11.40B	₩ 10.48B
Gross Profit	₩ -574.39M	₩ 660.07M	₩ 1.28B	₩ 2.56B	₩ 1.96B
Operating Income	₩ -4.33B	₩ -6.09B	₩ -6.15B	₩ 44.02B	₩ -7.69B
EBITDA	₩ -3.97B	₩ 17.23B	₩ 13.34B	₩ 45.46B	₩ -7.03B
Net Income	₩ 5.82B	₩ 16.12B	₩ 18.86B	₩ -119.69B	₩ 94.12B
Balance Sheet
Cash & Short-Term Investments	₩ 901.70M	₩ 5.72B	₩ 6.09B	₩ 9.29B	₩ 23.15B
Total Assets	₩ 159.99B	₩ 162.73B	₩ 151.31B	₩ 141.81B	₩ 274.47B
Total Debt	₩ 1.17B	₩ 894.79M	₩ 593.26M	₩ 1.77B	₩ 13.41B
Net Debt	₩ 266.07M	₩ -4.82B	₩ -5.50B	₩ -7.52B	₩ -9.74B
Total Liabilities	₩ 2.35B	₩ 2.89B	₩ 2.62B	₩ 37.40B	₩ 96.45B
Stockholders' Equity	₩ 157.64B	₩ 159.84B	₩ 148.68B	₩ 104.42B	₩ 178.02B
Cash Flow
Free Cash Flow	₩ -5.60B	₩ -117.41M	₩ -1.38B	₩ -11.84B	₩ -9.47B
Operating Cash Flow	₩ -5.55B	₩ -33.13M	₩ -1.05B	₩ -11.51B	₩ -7.07B
Investing Cash Flow	₩ 466.48M	₩ -74.22M	₩ -192.72M	₩ -15.92B	₩ -40.44B
Financing Cash Flow	₩ 272.97M	₩ -265.30M	₩ -1.96B	₩ 13.57B	₩ 61.54B

Currency in KRW

INBIOGEN CO., Ltd. Earnings and Revenue History

Income Statement >

INBIOGEN CO., Ltd. Debt to Assets

Balance Sheet >

INBIOGEN CO., Ltd. Cash Flow

Cash Flow >

INBIOGEN CO., Ltd. Forecast EPS vs Actual EPS

Earnings >